Maxigen Biotech Inc (1783) — Working Capital to Net Assets Ratio
Maxigen Biotech Inc (1783) has a Working Capital to Net Assets ratio of 47.1% as of June 2026. Working capital of NT$706.35 Million (current assets of NT$1.24 Billion minus current liabilities of NT$529.80 Million) is measured against net assets of NT$1.50 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Maxigen Biotech Inc (1783) liquidity interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Maxigen Biotech Inc Working Capital to Net Assets (2009–2025)
This chart shows how Maxigen Biotech Inc's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2009 to 2025. As of June 2026, the ratio stands at 47.1%, reflecting working capital of NT$706.35 Million against net assets of NT$1.50 Billion TWD. For the complete balance sheet picture, see Maxigen Biotech Inc balance sheet assets.
Annual Working Capital to Net Assets for Maxigen Biotech Inc (2009–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Maxigen Biotech Inc from 2009 to 2025, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check how resilient are Maxigen Biotech Inc's assets to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 50.2% | NT$772.36 Million | NT$1.54 Billion | NT$1.12 Billion | NT$349.11 Million | ▲ +4.8 pp |
| 2024 | 45.4% | NT$624.47 Million | NT$1.38 Billion | NT$830.33 Million | NT$205.87 Million | ▲ +9.5 pp |
| 2023 | 35.9% | NT$488.19 Million | NT$1.36 Billion | NT$619.56 Million | NT$131.37 Million | ▼ -29.1 pp |
| 2022 | 65.0% | NT$841.75 Million | NT$1.30 Billion | NT$993.25 Million | NT$151.50 Million | ▲ +6.5 pp |
| 2021 | 58.5% | NT$667.49 Million | NT$1.14 Billion | NT$783.55 Million | NT$116.07 Million | ▲ +18.3 pp |
| 2020 | 40.2% | NT$345.47 Million | NT$860.23 Million | NT$432.06 Million | NT$86.58 Million | ▲ +2.8 pp |
| 2019 | 37.4% | NT$318.20 Million | NT$851.32 Million | NT$640.15 Million | NT$321.95 Million | ▲ +0.9 pp |
| 2018 | 36.4% | NT$307.14 Million | NT$842.98 Million | NT$599.52 Million | NT$292.39 Million | ▼ -26.6 pp |
| 2017 | 63.1% | NT$502.12 Million | NT$796.25 Million | NT$585.10 Million | NT$82.98 Million | ▲ +0.8 pp |
| 2016 | 62.2% | NT$486.34 Million | NT$781.38 Million | NT$574.01 Million | NT$87.68 Million | ▼ -14.8 pp |
| 2015 | 77.0% | NT$639.20 Million | NT$829.86 Million | NT$702.54 Million | NT$63.34 Million | ▲ +9.4 pp |
| 2014 | 67.6% | NT$593.03 Million | NT$877.01 Million | NT$658.09 Million | NT$65.06 Million | ▼ -15.6 pp |
| 2013 | 83.2% | NT$739.30 Million | NT$888.39 Million | NT$788.21 Million | NT$48.91 Million | ▲ +7.2 pp |
| 2012 | 76.0% | NT$292.99 Million | NT$385.66 Million | NT$333.02 Million | NT$40.04 Million | ▲ +1.9 pp |
| 2011 | 74.1% | NT$273.45 Million | NT$369.25 Million | NT$310.79 Million | NT$37.34 Million | ▼ -13.2 pp |
| 2010 | 87.2% | NT$344.81 Million | NT$395.39 Million | NT$379.11 Million | NT$34.30 Million | ▲ +5.2 pp |
| 2009 | 82.0% | NT$256.81 Million | NT$313.03 Million | NT$287.26 Million | NT$30.45 Million | — |